Results 201 to 210 of about 55,959 (291)

Severe Hypoglycemia and Incidence of QT Interval Prolongation Among Adults With Type 2 Diabetes.

J Clin Endocrinol Metab, 2022
Kaze AD, Yuyun MF, Erqou S, Fonarow GC, Echouffo-Tcheugui JB.   +4 more
europepmc   +1 more source

No QTcF Prolongation with Sepiapterin: Results From a Thorough QT Study in Healthy Subjects at Therapeutic and Supratherapeutic Doses

The Journal of Clinical Pharmacology, Volume 66, Issue 1, January 2026.
Abstract Sepiapterin and its major metabolite 6R‐L‐erythro‐5,6,7,8‐tetrahydrobiopterin (BH4) bind to distinct variants of phenylalanine hydroxylase (PAH), which converts excess phenylalanine to tyrosine, thereby stabilizing, enhancing, and prolonging PAH activity.
Lan Gao, Hongqi Xue, Borje Darpo, Kimberly Ingalls, Diksha Kaushik, Neil Smith, Ronald Kong, Lee Golden   +7 more
wiley   +1 more source

Early Initiation of Enzyme Replacement Therapy in Infantile Onset Pompe Disease Improves Cardiac Outcomes: A Longitudinal Analysis

JIMD Reports, Volume 67, Issue 1, January 2026.
ABSTRACT The objective of this study is to evaluate whether early enzyme replacement therapy (ERT) initiation is associated with a lower incidence of echocardiogram abnormalities and cardiac conduction abnormalities compared to later ERT initiation.
Jennifer L. Cohen, M. Makenzie Beaman, Eleanor Rodriguez‐Rassi, V. Grace Stafford, P. Brian Smith, Andrew P. Landstrom, Priya S. Kishnani   +6 more
wiley   +1 more source

Does COVID-19 impact the QT interval prolongation? Answers from genetic causal inference. [PDF]

Biosci Rep
Song Y, Zheng Z.
europepmc   +1 more source

Predicting QT interval prolongation in patients diagnosed with the 2019 novel coronavirus infection. [PDF]

Ann Noninvasive Electrocardiol, 2021
Zhao W, Gandhi N, Affas S, Szpunar S, Mesiha N, Saravolatz L.   +5 more
europepmc   +1 more source

QT interval prolongation and torsades de pointes with oxaliplatin [PDF]

, 2016
Jules C. Hancox, Rachel E. Caves, Stéphanie C.M. Choisy, Andrew F. James   +3 more
openalex   +1 more source

QT interval prolongation as predictor of sudden death in patients with myocardial infarction.

Circulation, 1978
P. Schwartz, S. Wolf
semanticscholar   +1 more source

Treatable Neonatal Molybdenum Cofactor Deficiency: Rapid Demise Despite Rapid Biochemical Diagnosis

JIMD Reports, Volume 67, Issue 1, January 2026.
ABSTRACT Molybdenum cofactor deficiency (MoCD) is an inborn error of metabolism included in the differential for refractory neonatal seizures. The prognosis is guarded, with a median reported age of death between 2.4 and 3.0 years. Mortality is primarily due to seizures and lower respiratory tract infections.
Molly M. Crenshaw, Yasmeen Midgette, Shruthi Mohan, Ruhan Wei, Mariele Anneling, Monika Williams, Milap Patel, Benjamin T. Cocanougher, Sarah P. Young, Dmitriy Niyazov, Areeg El‐Gharbawy, Ashlee R. Stiles   +11 more
wiley   +1 more source

Impact of hypokalemia on Brugada syndrome: case report unveiling mechanisms beyond QT interval prolongation. [PDF]

Egypt Heart J
Siregar MNI, Wahidji VH.
europepmc   +1 more source

Reversing Acute Cardiomyopathy With Coenzyme Q10 Supplementation in Cobalamin B Disease: A Case Report and Literature Review

JIMD Reports, Volume 67, Issue 1, January 2026.
ABSTRACT Methylmalonic acidemia (MMA) is a rare metabolic disorder with various subtypes, including Cobalamin B (cblB) disease. While cardiac complications are well‐documented in propionic acidemia, their occurrence in MMA is less understood. Here, we report a 12‐year‐old child with cblB disorder who developed acute cardiomyopathy (CM).
Dalia Said, Aisha Al Shamsi
wiley   +1 more source